The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Biomarker Amplification by Serum Carrier Protein Binding
Open accessAbstract
Mass spectroscopic analysis of the low molecular mass (LMM) range of the serum/plasma proteome is a rapidly emerging frontier for biomarker discovery. This study examined the proportion of LMM biomarkers, which are bound to circulating carrier proteins. Mass spectroscopic analysis of human serum following molecular mass fractionation, demonstrated that the majority of LMM biomarkers exist bound to carrier proteins. Moreover, the pattern of LMM biomarkers bound specifically to albumin is distinct from those bound to non‐albumin carriers. Prominent SELDI‐TOF ionic species (m/z 6631.7043) identified to correlate with the presence of ovarian cancer were amplified by albumin capture. Several insights emerged: a) Accumulation of LMM biomarkers on circulating carrier proteins greatly amplifies the total serum/plasma concentration of the measurable biomarker, b) The total serum/plasma biomarker concentration is largely determined by the carrier protein clearance rate, not the unbound biomarker clearance rate itself, and c) Examination of the LMM species bound to a specific carrier protein may contain important diagnostic information. These findings shift the focus of biomarker detection to the carrier protein and its biomarker content.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Anderson, N. L., & Anderson, N. G. (2002) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r200007-mcp200 · Cited by 4,414
Use of proteomic patterns in serum to identify ovarian cancer
Petricoin, E. F., Ardekani, A. M., Hitt, B. A., Levine, P. J., Fusaro, V. A., Steinberg, S. M., Mills, G. B., Simone, C., Fishman, D. A., Kohn, E. C., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07746-2 · Cited by 3,236
Self-citation
Cited by
The blood peptidome: a higher dimension of information content for cancer biomarker discovery
Petricoin, E. F., Belluco, C., Araujo, R. P., & Liotta, L. A. (2006) · Nature Reviews Cancer · doi:10.1038/nrc2011 · Cited by 357
Self-citationSELDI-TOF-based serum proteomic pattern diagnostics for early detection of cancer
Petricoin, E. F., & Liotta, L. A. (2004) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2004.01.005 · Cited by 331
Self-citationUtilizing Human Blood Plasma for Proteomic Biomarker Discovery
Jacobs, J. M., Adkins, J. N., Qian, W.-J., Liu, T., Shen, Y., Camp, D. G., & Smith, R. D. (2005) · Journal of Proteome Research · doi:10.1021/pr0500657 · Cited by 316
Discovery of Protein Biomarkers for Renal Diseases
Hewitt, S. M., Dear, J., & Star, R. A. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000129114.92265.32 · Cited by 295
High-resolution serum proteomic features for ovarian cancer detection.
Conrads, T. P., Fusaro, V. A., Ross, S., Johann, D., Rajapakse, V, Hitt, B. A., Steinberg, S. M., Kohn, E. C., Fishman, D. A., Whitely, G., et al. (2004) · Endocrine-related cancer · doi:10.1677/erc.0.0110163 · Cited by 260
Self-citation
Metadata
- Authors
- Mehta, A. I., Ross, S., Lowenthal, M. S., Fusaro, V., Fishman, D. A., Petricoin, E. F., & Liotta, L. A.
- Venue
- Disease Markers
- Publisher
- Wiley
- Published
- 2003-01
- Volume
- 19
- Issue
- 1
- Pages
- 1-10
- ISSN
- 0278-0240 (ISSN-L)
- 1875-8630
- OpenAlex
- W2169182264
- Cited by
- 208
- References
- 2
- FWCI
- 13.17
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Biomarker Amplification by Serum Carrier Protein Binding. https://app.cochat.ai/papers/10.1155/2003/104879
- The paper
- Mehta, A. I., Ross, S., Lowenthal, M. S., Fusaro, V., Fishman, D. A., Petricoin, E. F., & Liotta, L. A. (2003). Biomarker Amplification by Serum Carrier Protein Binding. Disease Markers. https://doi.org/10.1155/2003/104879
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.